Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, Colombia

BMC Infectious Diseases

Volumn 1, Issue , 2001, Pages

  Murcia Aranguren, Martha I ^a   Gómez Marin, Jorge E ^a,b   Alvarado, Fernando S ^a   Bustillo, José G ^c   de Mendivelson, Ellen ^c   Gómez, Bertha ^d   León, Clara I ^e   Triana, William A ^a   Vargas, Erwing A ^a   Rodríguez, Edgar ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DEL QUINDÍO   (Colombia)

^c Plastic and Reconstructive Surgery Department of the Hospital Simón Bolivar   (Colombia)

^d Instituto de Seguros Sociales Bogota   (Colombia)

^e INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD ANALYSIS; BLOOD SMEAR; BODY FLUID; CHILD; COLOMBIA; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; EXTRAPULMONARY TUBERCULOSIS; FECES ANALYSIS; FEMALE; HEALTH CENTER; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; SPUTUM ANALYSIS; STAINING; URINALYSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PILOT STUDY; PRESCHOOL CHILD; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COLOMBIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PILOT PROJECTS; TUBERCULOSIS;

EID: 2942560563     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-1-21     Document Type: Article

References (30)

1. Center for Disease Control and Prevention: Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility-Michigan. MMWR Morb Mortal Wkly Rep 1991, 40:129-131
2. Center for Disease Control and Prevention: Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991, 40:585-591
3. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, Hopewell PC: An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992, 326:231-235
4. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, KR Ong, Kilburn JO, Dooley SW, Castro KG, et al: An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992, 326:1514-1521
5. Victoria JE: Epidemiologia de la tuberculosis en Colombia. Informe Quincenal Epidemiológico Nacional 1999, 4:82-85
6. Allen S, Batungwanayo J, Kerlikowske K, Lifson AR, Wolf W, Granich R, Taelman H, Van de Perre P, Serufilira A, Bogaerts J J, et al: Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis 1992, 146:1439-1444
7. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE: High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992, 268:504-509
8. Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miro JM, Mallolas J, Zamora L, Gonzalez J, et al: A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993, 7:1345-139
9. Moreno S S, Baraia-Etxaburo J, Bouza E, Parras F, Perez-Tascon M, Miralles P, et al: Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993, 119:194-198
10. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD: Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993, 342:268-272
11. Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, Capps L, Brown LS, Carlyn M, Korvick JA, et al: Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1994, 272:1915-1921
12. Graham NM, Cohn S, Galai N, Astemborski J, Nelson KE, Vlahov D: Incidence of mycobacterial infection and disease in HIV+ and HIV- IDUs [Abstract]. Int Conf AIDS 1993, 9:328
13. Antonucci G, Girardi E, Raviglione MC, Ippolito G: Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995, 274:143-148
14. Dupon M, Texier-Maugein J, Leroy V, Sentilhes A, Pellegrin JL, Morlat P, et al: Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985-1993. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AIDS 1995, 9:577-583
15. Horsburgh CR: Mycobacterium avium-complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991, 324:1332-1338
16. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, et al: Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993, 329:1922-1926
17. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T: Incidence and natural history of Mycobacterium aviu m-complex infections in patients with advanced HIV disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis 1992, 146:285-289
18. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA: Incidence of Mycobacterium avium - intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992, 165:1082-1085
19. Horsburgh CR, Havlik JA, Ellis DA, Kennedy E, Fann SA, Dubois RE, Thompson SE: Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 1991, 144:557-559
20. Jacobson MA, Hopewell PC, Yajko DM, Hadley WK, Lazarus E, Mohanty PK, GW Modin, Feigal DW, Cusick PS, Sande MA: Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991, 164:994-998
21. Instituto Nacional de Salud: Tuberculosis, Manual de Procedimientos Bogota 1990
22. Center for Diseases Control: Mycobacteriology, A guide for the level III laboratory Atlanta 1985
23. Rothman KJ: Modern Epidemiology. Boston: Little, Brown 1986, 155, 172:196-213
24. Kahn HA, Sempos CT: Statistical Methods in Epidemiology New York: Oxford Univ Pr 1989219
25. Murcia M, León CI, de la Hoz F, Saravia J: Frecuencia de las infecciones micobacterianas en pacientes VIH positivos que acuden a las consultas del Hospital san Juan de Dios. Biomedica 1996, 16(suppl 1):23
26. Crespo MP, Corral R, Alzate A: El diagnostico de la infección por micobacterias en individuos VIH positivos. Colombia Medica 1994, 25:86-91
27. Conde MB, Figueira CM, Moraes R, Fonseca LS, Deriemer K, Kritski AL: Predictive value of the acid fast smear for detection of Mycobacterium tuberculosis in respiratory specimens in a reference center of HIV/AIDS in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 1999, 94:787-790
28. Horsburgh CR: Epidemiology of mycobacterial diseases in AIDS. Res Microbiol 1992, 143:372-377
29. Coker RJ, Hellyer TJ, Brown IN, Weber JN: Clinical aspects of mycobacterial infections in HIV infection. Res Microbiol 1992, 143:377-381
30. Gómez Marin JE, Rigouts L, Villegas Londoño LE, Portaels F: Restriction Fragment Length Polymorphism (RFLP) analysis and tuberculosis epidemiology. Bull PAHO 1995, 29:226-236